Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 195
Filtrer
1.
Emerg Infect Dis ; 30(13): S88-S93, 2024 04.
Article de Anglais | MEDLINE | ID: mdl-38561855

RÉSUMÉ

Correctional facilities house millions of residents in communities throughout the United States. Such congregate settings are critical for national infection prevention and control (IPC) efforts. Carceral settings can be sites where infectious diseases are detected in patient populations who may not otherwise have access to health care services, and as highlighted by the COVID-19 pandemic, where outbreaks of infectious diseases may result in spread to residents, correctional staff, and the community at large. Correctional IPC, while sharing commonalities with IPC in other settings, is unique programmatically and operationally. In this article, we identify common challenges with correctional IPC program implementation and recommend action steps for advancing correctional IPC as a national public health priority.


Sujet(s)
COVID-19 , Maladies transmissibles , Humains , États-Unis/épidémiologie , Prisons , Pandémies/prévention et contrôle , COVID-19/épidémiologie , COVID-19/prévention et contrôle , Prévention des infections
2.
J Dairy Sci ; 106(10): 6880-6893, 2023 Oct.
Article de Anglais | MEDLINE | ID: mdl-37210373

RÉSUMÉ

This study investigated the effect of feeding seaweed (Ascophyllum nodosum) to dairy cows on milk mineral concentrations, feed-to-milk mineral transfer efficiencies, and hematological parameters. Lactating Holstein cows (n = 46) were allocated to 1 of 2 diets (n = 23 each): (1) control (CON; without seaweed) and (2) seaweed (SWD; replacing 330 g/d of dried corn meal in CON with 330 g/d dried A. nodosum). All cows were fed the CON diet for 4 wk before the experiment (adaptation period), and animals were then fed the experimental diets for 9 wk. Samples included sequential 3-wk composite feed samples, a composite milk sample on the last day of each week, and a blood sample at the end of the study. Data were statistically analyzed using a linear mixed effects model with diet, week, and their interaction as fixed factors; cow (nested within diet) as a random factor; and data collected on the last day of the adaptation period as covariates. Feeding SWD increased milk concentrations of Mg (+6.6 mg/kg), P (+56 mg/kg), and I (+1,720 µg/kg). It also reduced transfer efficiency of Ca, Mg, P, K, Mn, and Zn, and increased transfer efficiency of Mo. Feeding SWD marginally reduced milk protein concentrations, whereas there was no effect of SWD feeding on cows' hematological parameters. Feeding A. nodosum increased milk I concentrations, which can be beneficial when feed I concentration is limited or in demographics or populations with increased risk of I deficiency (e.g., female adolescents, pregnant women, nursing mothers). However, care should also be taken when feeding SWD to dairy cows because, in the present study, milk I concentrations were particularly high and could result in I intakes that pose a health risk for children consuming milk.


Sujet(s)
Ascophyllum , Algue marine , Enfant , Bovins , Femelle , Grossesse , Animaux , Humains , Adolescent , Lactation , Aliment pour animaux/analyse , Régime alimentaire/médecine vétérinaire , Minéraux/pharmacologie , Légumes , Compléments alimentaires
3.
Ann Intern Med ; 175(12): 1742-1745, 2022 12.
Article de Anglais | MEDLINE | ID: mdl-36410006

RÉSUMÉ

The American College of Physicians (ACP) has a long-standing commitment to improving the health of all Americans and opposes any form of discrimination in the delivery of health care services. ACP is committed to working toward fully understanding and supporting the unique needs of the incarcerated population and eliminating health disparities for these persons. In this position paper, ACP offers recommendations to policymakers and administrators to improve the health and well-being of persons incarcerated in adult correctional facilities.


Sujet(s)
Médecins , Prisonniers , Adulte , Humains , États-Unis , Prisons , Prestations des soins de santé , Politique (principe) , Politique de santé
4.
Hum Reprod Open ; 2022(3): hoac026, 2022.
Article de Anglais | MEDLINE | ID: mdl-35775066

RÉSUMÉ

STUDY QUESTION: What are the effects of pre-analytical variables on the downstream analysis of patient-derived endometrial biopsies? SUMMARY ANSWER: There are distinct differences in the protein levels of the master regulator of oxygen homeostasis, hypoxia-inducible factor-1-alpha (HIF1α), and the protein and mRNA levels of three related genes, carbonic anhydrase 9 (CA9), vascular endothelial growth factor A (VEGFA) and progesterone receptor (PR) in human endometrial biopsies, depending on the pre-analytical variables: disease status (cancer vs benign), timing of biopsy (pre- vs post-hysterectomy) and type of biopsy (pipelle vs full-thickness). WHAT IS KNOWN ALREADY: Patient-derived biopsies are vital to endometrial research, but pre-analytical variables relating to their collection may affect downstream analysis, as is evident in other tissues. STUDY DESIGN SIZE DURATION: A prospective observational study including patients undergoing hysterectomy for endometrial cancer (EC) or benign indications was conducted at a large tertiary gynaecological unit in the UK. Endometrial biopsies were obtained at different time points (pre- or post-hysterectomy) using either a pipelle endometrial sampler or as a full-thickness wedge biopsy. PARTICIPANTS/MATERIALS SETTING METHODS: The changes in HIF1α, CA9, VEGFA and PR protein levels were measured by semi-quantitative analysis of immunostaining, and the expression levels of three genes (CA9, VEGFA and PR) were investigated by quantitative real-time PCR, in endometrial biopsies from 43 patients undergoing hysterectomy for EC (n = 22) or benign gynaecological indications (n = 21). MAIN RESULTS AND THE ROLE OF CHANCE: An increase in HIF1α immunostaining was observed in EC versus benign endometrium (functionalis glands) obtained pre-hysterectomy (P < 0.001). An increase in CA9 immunostaining was observed in EC versus benign endometrial functionalis glands at both pre- and post-hysterectomy time points (P = 0.03 and P = 0.003, respectively). Compared with benign endometrial pipelle samples, EC samples demonstrated increased mRNA expression of CA9 (pre-hysterectomy P < 0.001, post-hysterectomy P = 0.008) and VEGFA (pre-hysterectomy P = 0.004, post-hysterectomy P = 0.002). In benign uteri, HIF1α immunoscores (functionalis glands, P = 0.03 and stroma, P = 0.009), VEGFA immunoscores (functionalis glands, P = 0.03 and stroma, P = 0.01) and VEGFA mRNA levels (P = 0.008) were increased in matched post-hysterectomy versus pre-hysterectomy samples. Similarly, in EC, an increase in VEGFA immunoscores (epithelial and stromal) and VEGFA mRNA expression was observed in the matched post-hysterectomy versus pre-hysterectomy biopsies (P = 0.008, P = 0.004 and P = 0.018, respectively). Full-thickness benign post-hysterectomy endometrial biopsies displayed increased VEGFA (P = 0.011) and PR (P = 0.006) mRNA expression compared with time-matched pipelle biopsies. LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: This descriptive study explores the effect of pre-analytical variables on the expression of four proteins and three hypoxia-related genes in a limited number of endometrial biopsies from patients with EC and benign controls. Due to the small number, it was not possible to investigate other potential variables such as menstrual cycle phase, region-specific differences within the endometrium, grade and stage of cancer, and surgical technicalities. WIDER IMPLICATIONS OF THE FINDINGS: Careful consideration of the effects of these pre-analytical variables is essential when interpreting data relating to human endometrial biopsies. A standardized approach to endometrial tissue collection is essential to ensure accurate and clinically transferrable data. STUDY FUNDING/COMPETING INTERESTS: The authors have no conflicts of interest to declare. The work included in this manuscript was funded by Wellbeing of Women project grants RG1073 and RG2137 (D.K.H.), Wellbeing of Women Entry-Level Scholarship ELS706 and Medical Research Council MR/V007238/1 (A.M./D.K.H.), Liverpool Women's Hospital Cancer Charity (M.A.) and University of Liverpool (L.B., L.R. and E.N.).

5.
J Correct Health Care ; 28(1): 3-5, 2022 02.
Article de Anglais | MEDLINE | ID: mdl-34788551

RÉSUMÉ

As the United States wrestles with the consequences of the COVID-19 pandemic and concurrently confronts long-standing issues of racial injustice, it is more important than ever that criminal justice health becomes an integrated component of medical school curricula. Nearly all future physicians will someday be caring for justice-involved patients or their family members. A foundational medical school education that includes criminal justice health will better equip these physicians to not only care for their patients, but also help address health care disparities and the public health concerns that affect our communities. These recommended changes to U.S. medical school curricula will occur only with the commitment of academic leaders and their inclusion of medical school faculty with criminal justice health expertise to help guide these efforts. Now is the time for U.S. medical schools to embrace criminal justice health as essential learning.


Sujet(s)
COVID-19 , Étudiant médecine , Droit pénal , Programme d'études , Éducation pour la santé , Humains , Pandémies , SARS-CoV-2 , Écoles de médecine , États-Unis
6.
Eur J Obstet Gynecol Reprod Biol ; 263: 205-209, 2021 Aug.
Article de Anglais | MEDLINE | ID: mdl-34229184

RÉSUMÉ

OBJECTIVE: Women undergoing assisted reproductive treatment are usually concerned about the side effects caused by high doses of gonadotropin. A common inquiry of patients is concerning the weight gain as a consequence. The aim of this study was to evaluate if controlled ovarian stimulation increase the weight of women undergoing IVF treatment. Study design This retrospective cohort study included 734 women undergoing IVF treatment between January 2017 and May 2018 and had body weight measured on the day of ovarian stimulation starting (basal-weight) and on the hCG trigger day (hCG-weight). The difference of hCG-weight and basal-weight was calculated and correlated to number of oocytes retrieved and ovarian stimulation protocol. For 358 women, two international validated questionnaires to evaluate the anxiety and binge eating were applied at the end of ovarian stimulation and also associated to the body weight gain. RESULTS: The basal-weight and hCG-weight were paired compared and demonstrate a statistically significant weight gain from basal to hCG-weight of a mean of 387.7 ± 720.4 g (p < 0.001). The weight gain had a positive correlation with the number of oocytes retrieved (Pearson correlation, r = 0.181; p < 0.001) but no correlation with the ovarian stimulation protocol. Regarding the questionnaires answered by patients, neither anxiety score (Pearson: r = -0,031; p = 0,561) nor binge eating score (Pearson: r = 0,069; p = 0,199) were correlated with weight gain from basal-weight to hCG- weight. However, patients who felt eating more during the treatment had a higher weight gain (p < 0.001) independently of the number of oocytes retrieved. CONCLUSIONS: The weight gain is possibly a result from edema and is clinically irrelevant despite of the statistical significance and will probably be resolved in some days after oocytes retrieval. A small "weight gain" was observed and associated to the number of oocytes retrieved regardless of protocol and medication used in the ovarian stimulation.


Sujet(s)
Gonadotrophine chorionique , Fécondation in vitro , Femelle , Humains , Induction d'ovulation/effets indésirables , Grossesse , Taux de grossesse , Études rétrospectives
7.
Morphologie ; 105(351): 323-326, 2021 Dec.
Article de Anglais | MEDLINE | ID: mdl-33288422

RÉSUMÉ

Owing to the interconnected nature of the brain, anatomical variations in one area often coincide with, or are caused by, abnormalities in another. During dissection of a specimen with both Chiari I malformation and craniosynostosis, a persistent falcine sinus was observed to drain into the straight sinus. Such a variant should be noted by physicians as it could alter treatment plans and require more detailed imaging procedures prior to surgical correction. Herein, we report the case and discuss the possible embryological origins and clinical significance of the variant.


Sujet(s)
Craniosynostoses , Imagerie par résonance magnétique , Encéphale , Sinus veineux crâniens/imagerie diagnostique , Craniosynostoses/imagerie diagnostique , Humains , Planification des soins du patient
8.
J Correct Health Care ; 25(3): 277-286, 2019 07.
Article de Anglais | MEDLINE | ID: mdl-31242806

RÉSUMÉ

Transgender persons are at increased risk of victimization during incarceration and have unique health care needs. We convened a symposium of 27 key stakeholders to develop consensus on correctional policy, practice, and clinical care considerations for incarcerated transgender persons. Participants included formerly justice-involved transgender persons, correctional leaders, government authorities, academicians, advocates, health care providers, and expert consultants. Consensus considerations were developed in four areas: correctional practices that promote safety and respectful interactions with transgender inmates, training of correctional staff, health care delivery, and reentry to the community. Gaps in knowledge and practice in these four areas were also identified. A collaborative stakeholder model is an effective strategy to convene disparate groups who infrequently communicate with one another to help advance correctional policies and clinical care.


Sujet(s)
Processus politique , Prisons/organisation et administration , Personnes transgenres , Comportement coopératif , Humains , Relations interinstitutionnelles , Prisons/normes , Participation des parties prenantes
9.
Eur Rev Med Pharmacol Sci ; 23(2): 771-787, 2019 Jan.
Article de Anglais | MEDLINE | ID: mdl-30720186

RÉSUMÉ

Acute pancreatitis (AP) is the most common gastrointestinal disorder requiring hospitalization, with a high rate of morbidity and mortality. Severe AP is characterized by the presence of persistent organ failure involving single or multiple organs. Clinical evolution, laboratory and radiological assessment are necessary to evaluate the prognosis and inform the management of AP. The onset of severe AP may be classified in two principal phases. The early phase, during the first week, is characterized by the activation of the auto-inflammatory cascade, gut dysbiosis, bacterial translocation, and the down-regulation of immune responses. The late phase is characterized by the development of local and systemic complications. Several old paradigms have been amended in the management of AP patients, such as the indication of nutrition, the use of antibiotic therapy, pain control strategies, and even the use of surgery. Real world evidence has shown that in the majority of cases a step-up approach is most effective. In this review, we discuss the clinical assessment and improvements to the management of patients with severe AP in a high volume center where a multi-disciplinary approach is performed.


Sujet(s)
Défaillance multiviscérale/thérapie , Douleur/traitement médicamenteux , Pancréatite/thérapie , Équipe soignante , Analgésiques/usage thérapeutique , Antibactériens/usage thérapeutique , Translocation bactérienne/immunologie , Cholangiopancréatographie rétrograde endoscopique , Drainage/méthodes , Gastroentérostomie , Microbiome gastro-intestinal/immunologie , Humains , Défaillance multiviscérale/immunologie , Thérapie nutritionnelle/méthodes , Douleur/immunologie , Gestion de la douleur/méthodes , Pancréas/imagerie diagnostique , Pancréas/immunologie , Pancréas/anatomopathologie , Pancréas/chirurgie , Pancréatite/complications , Pancréatite/diagnostic , Pancréatite/immunologie , Indice de gravité de la maladie , Tomodensitométrie
10.
J Public Health Manag Pract ; 25(2): E1-E6, 2019.
Article de Anglais | MEDLINE | ID: mdl-30024493

RÉSUMÉ

CONTEXT: Correctional facilities provide unique opportunities to diagnose and treat persons with latent tuberculosis infection (LTBI). Studies have shown that 12 weekly doses of isoniazid and rifapentine (INH-RPT) to treat LTBI resulted in high completion rates with good tolerability. OBJECTIVE: To evaluate completion rates and clinical signs or reported symptoms associated with discontinuation of 12 weekly doses of INH-RPT for LTBI treatment. SETTING/PARTICIPANTS: During July 2012 to February 2015, 7 Federal Bureau of Prisons facilities participated in an assessment of 12 weekly doses of INH-RPT for LTBI treatment among 463 inmates. MAIN OUTCOME MEASURES: Fisher exact test was used to assess the associations between patient sociodemographic characteristics and clinical signs or symptoms with discontinuation of treatment. RESULTS: Of 463 inmates treated with INH-RPT, 424 (92%) completed treatment. Reasons for discontinuation of treatment for 39 (8%) inmates included the following: 17 (44%) signs/symptoms, 9 (23%) transfer or release, 8 (21%) treatment refusal, and 5 (13%) provider error. A total of 229 (49.5%) inmates reported experiencing at least 1 sign or symptom during treatment; most frequently reported were fatigue (16%), nausea (13%), and abdominal pain (7%). Among these 229 inmates, signs/symptoms significantly associated with discontinuation of treatment included abdominal pain (P < .001), appetite loss (P = .02), fever/chills (P = .01), nausea (P = .03), sore muscles (P = .002), and elevation of liver transaminases 5× upper limits of normal or greater (P = .03). CONCLUSIONS: The LTBI completion rates were high for the INH-RPT regimen, with few inmates discontinuing because of signs or symptoms related to treatment. This regimen also has practical advantages to aid in treatment completion in the correctional setting and can be considered a viable alternative to standard LTBI regimens.


Sujet(s)
Isoniazide/usage thérapeutique , Tuberculose latente/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Prisons/statistiques et données numériques , Rifampicine/analogues et dérivés , Adulte , Antituberculeux/usage thérapeutique , Thérapie sous observation directe/méthodes , Thérapie sous observation directe/normes , Thérapie sous observation directe/statistiques et données numériques , Femelle , Humains , Tuberculose latente/psychologie , Mâle , Adulte d'âge moyen , Mycobacterium/effets des médicaments et des substances chimiques , Mycobacterium/pathogénicité , Projets pilotes , Études prospectives , Rifampicine/usage thérapeutique
11.
Curr Med Chem ; 25(42): 6070-6081, 2018.
Article de Anglais | MEDLINE | ID: mdl-29773050

RÉSUMÉ

BACKGROUND: Vaccines are very effective medical tools for disease prevention and life span increase. Controversies have raised concern about their safety, from autism to polio vaccine contamination with simian virus 40 (SV-40). Hysteria surrounding vaccine-associated risks has resulted in a declining number of vaccinations in developed countries. Outbreaks of vaccine-preventable diseases (e.g. measles) have occurred in Europe and North America, causing also some causalities. OBJECTIVES: In this review, data on safety and efficacy of vaccines are discussed, showing that the benefits of vaccines far outweigh the risks and that it is important to comply with vaccination protocols, to avoid spreading of severe, preventable diseases. METHODS: Those opposed to vaccinations suggest that scientific literature supporting vaccines is influenced by pharmaceutical companies. In this review, studies on influenza produced by independent scientists and those authored by those who received some kind of benefit from the industry are discussed separately. All the chosen papers were selected through a MEDLINE research. RESULTS: Vaccination rates are decreasing, even though they are effective public health tools. Influenza, for example, is responsible for 250,000-500,000 deaths each year, according to the WHO. Yet, campaigns to extend influenza vaccine to all elderly subjects report little success, because of the vaccine scare and because not all patients develop immunity following vaccination. CONCLUSIONS: This review proves that vaccine hysteria is detrimental because: 1) it causes an increased morbidity and mortality from preventable diseases; 2) it jeopardizes research for new vaccines; 3) patients are reluctant to accept any form of immune-therapy, commonly referred to as "vaccination".


Sujet(s)
Vaccination/psychologie , Vaccins/effets indésirables , Trouble du spectre autistique/étiologie , Pays développés , Syndrome de Guillain-Barré/étiologie , Humains , Grippe humaine/immunologie , Grippe humaine/prévention et contrôle , Grippe humaine/psychologie , Médecine préventive , Thiomersal/effets indésirables , Vaccination/statistiques et données numériques , Vaccins/immunologie
12.
Mediators Inflamm ; 2018: 7946431, 2018.
Article de Anglais | MEDLINE | ID: mdl-29563853

RÉSUMÉ

Gut microbiota is key to the development and modulation of the mucosal immune system. It plays a central role in several physiological functions, in the modulation of inflammatory signaling and in the protection against infections. In healthy states, there is a perfect balance between commensal and pathogens, and microbiota and the immune system interact to maintain gut homeostasis. The alteration of such balance, called dysbiosis, determines an intestinal bacterial overgrowth which leads to the disruption of the intestinal barrier with systemic translocation of pathogens. The pancreas does not possess its own microbiota, and it is believed that inflammatory and neoplastic processes affecting the gland may be linked to intestinal dysbiosis. Increasing research evidence testifies a correlation between intestinal dysbiosis and various pancreatic disorders, but it remains unclear whether dysbiosis is the cause or an effect. The analysis of specific alterations in the microbiome profile may permit to develop novel tools for the early detection of several pancreatic disorders, utilizing samples, such as blood, saliva, and stools. Future studies will have to elucidate the mechanisms by which gut microbiota is modulated and how it tunes the immune system, in order to be able to develop innovative treatment strategies for pancreatic disorders.


Sujet(s)
Microbiome gastro-intestinal/physiologie , Maladies du pancréas/métabolisme , Animaux , Microbiome gastro-intestinal/génétique , Humains , Système immunitaire/immunologie , Système immunitaire/métabolisme , Microbiote/physiologie , Maladies du pancréas/immunologie , Maladies du pancréas/microbiologie
13.
Article de Anglais | MEDLINE | ID: mdl-27464353

RÉSUMÉ

The symptom literature in cancer has primarily examined symptom severity, frequency and distress. Assessing cancer patients' perceptions of symptom importance-how important it is for them to see improvement in a symptom following an intervention-and factors influencing these judgments would also inform patient-centred care, but this analysis has not been undertaken. This qualitative study aimed to identify factors underlying perceptions of symptom importance among 25 symptomatic metastatic breast cancer (MBC) patients. Participants were recruited from a cancer centre in the Midwestern USA. Semi-structured interviews focused on patients' rationale for considering common symptoms (i.e., anxiety, sadness, sleep problems, pain or fatigue) to be important. Thematic analyses revealed five interrelated factors underlying MBC patients' perceptions of symptom importance: activity restriction, concentration difficulties, exacerbation of other physical symptoms, symptom-related long-term health concerns and negative impact on their relationships with others. Patients most frequently stated that a physical or psychological symptom was important because of the resulting activity restriction. Additionally, some patients considered pain to be important because it signalled potential long-term health concerns, such as worsening metastatic disease. Findings suggest that clinicians should take into account MBC patients' perceptions of symptom importance and factors underlying these judgments when making shared treatment decisions.


Sujet(s)
Attitude envers la santé , Tumeurs du sein/psychologie , Activités de la vie quotidienne , Adulte , Sujet âgé , Anxiété/étiologie , Attention/physiologie , Émotions , Fatigue/étiologie , Femelle , Humains , Relations interpersonnelles , Adulte d'âge moyen , États du Centre-Ouest des États-Unis , Métastase tumorale , Douleur/psychologie , Perception
14.
Anaesthesia ; 72(6): 765-777, 2017 Jun.
Article de Anglais | MEDLINE | ID: mdl-28654173

RÉSUMÉ

This systemic review was performed to determine whether rocuronium creates intubating conditions comparable to those of succinylcholine during rapid sequence intubation of the trachea. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 2), MEDLINE (1966 to February Week 2 2015), and EMBASE (1988 to February 14 2015) for any randomised controlled trials or controlled clinical trials that reported intubating conditions comparing rocuronium and succinylcholine for rapid or modified rapid sequence intubation. The dose of rocuronium was at least 0.6 mg.kg-1 and succinylcholine was at least 1 mg.kg-1 . Sixty-six studies were identified and 50 included, representing 4151 participants. Overall, succinylcholine was superior to rocuronium for achieving excellent intubating conditions (risk ratio (95%CI) 0.86 (0.81 to 0.92), n = 4151) and clinically acceptable intubation conditions (risk ratio (95%CI) 0.97 (0.95-0.99), n = 3992). A high incidence of detection bias amongst the trials coupled with significant heterogeneity means that the quality of evidence was moderate for these conclusions. Succinylcholine was more likely to produce excellent intubating conditions when using thiopental as the induction agent: risk ratio (95%CI) 0.81 (0.73-0.88), n = 2302) with or without the use of opioids (risk ratio (95%CI) 0.85 (0.78-0.93), n = 2292 or 0.85 (0.76-0.95), n = 1428).


Sujet(s)
Intubation trachéale/méthodes , Curarisants dépolarisants , Curarisants non dépolarisants , Rocuronium , Suxaméthonium , Humains , Essais contrôlés randomisés comme sujet
15.
Eur Rev Med Pharmacol Sci ; 20(17): 3618-27, 2016 09.
Article de Anglais | MEDLINE | ID: mdl-27649663

RÉSUMÉ

OBJECTIVE: To study the 3' immunoglobulin heavy-chain regulatory region (3'RR) enhancer complex, active in class switching recombination and in B-cells, in Crohn's disease. PATIENTS AND METHODS: A total of 167 patients [79 females (47.3%) and 88 males (52.7%)] affected by Crohn's disease were enrolled in the study. As a control, we included 64 healthy subjects, age and sex matched, from the same geographical area. Blood tests were performed on all subjects to determine their antibody levels and to detect the presence of any possible infections. We conducted a selective PCR, which amplified the hs1.2-A region. The nested second PCR to amplify the polymorphic core of the enhancer was performed. RESULTS: No differences between cases and controls were observed with respect to sex distribution (43.8% females among controls and 49.5% among cases), age, tTG IgA, RF, serum or secretory IgA, IgG1, IgG2 and IgG3. No correlation was found between both seric and secretory immunoglobulins levels, with except of statistically significant differences between cases and controls with respect to IgA and IgG ASCA positivity (p<0.001), serum IgG4 (p<0.001) and IgD (p=0.001). CONCLUSIONS: We have demonstrated that in Crohn's disease, the HS1,2 immunoglobulins enhancer is not implicated in the disease pathogenesis. Moreover, we have found that IgG4 levels are lower in Crohn's disease patients than in controls; these data may be related to an impairment of number and function of Tregs, further linked to the presence of tissue inflammation. Crohn's disease is a complex multifactorial disease. The pathogenesis of Crohn's disease is incompletely understood although it is clear that the disease involves multiple interacting agents.


Sujet(s)
Maladie de Crohn/génétique , Immunoglobuline G/génétique , Adulte , Anticorps bloquants , Femelle , Humains , Mâle , Adulte d'âge moyen , Réaction de polymérisation en chaîne
17.
J Otolaryngol Head Neck Surg ; 45: 24, 2016 Apr 11.
Article de Anglais | MEDLINE | ID: mdl-27066834

RÉSUMÉ

BACKGROUND: Many treatment options exist for the management of anterior epistaxis. However, little is known about treatment outcomes. The objective was to identify the currently utilised methods of management and outcomes for patients with anterior epistaxis presenting to the emergency department (ED) at a Canadian tertiary care center. METHODS: A retrospective review of ED visits from January 2012-May 2014 for adult patients with a diagnosis of anterior epistaxis was performed. Patient demographic data, comorbidities, and treatment methods were documented. The effectiveness of different treatment modalities was determined. RESULTS: Three hundred fifty-three primary anterior epistaxis cases were included. Mean patient age was 70 years and 49% of patients were female. Comorbidities included hypertension (56%), diabetes (19%), CAD (28%), and atrial fibrillation (27%). A large proportion of the cohort (61%) was on at least one anticoagulant or antiplatelet therapy. The most common utilised treatment modalities were silver nitrate cauterization, Merocel®, petroleum gauze packing, nasal clip and 15% were simply observed. Initial treatment success was achieved in 74% of cases. Of patients receiving specific treatment modalities, silver nitrate cauterization had the highest success rate at 80%. 26% of patients returned to the ED for recurrence of epistaxis with highest rates occurring in the nasal clip (59%), Merocel® (26%), and petroleum gauze packing (42%) groups. CONCLUSIONS: The differences in recurrence rate among the different treatment modalities observed may be due to true differences in effectiveness or differences in treatment selection by the ED physicians based on severity of epistaxis. Cauterization with silver nitrate, however, offers the added benefit of no need for follow up. Further study is needed to elucidate the most efficacious treatment modality based on epistaxis severity.


Sujet(s)
Prise en charge de la maladie , Service hospitalier d'urgences , Épistaxis/thérapie , Techniques d'hémostase , /méthodes , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Canada , Épistaxis/diagnostic , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Indice de gravité de la maladie , Jeune adulte
19.
J Immunol Res ; 2015: 123653, 2015.
Article de Anglais | MEDLINE | ID: mdl-26090475

RÉSUMÉ

Celiac disease (CD) is an immune-mediated enteropathy, triggered by dietary wheat gluten and similar proteins of barley and rye in genetically susceptible individuals. This is a complex disorder involving both environmental and immune-genetic factors. The major genetic risk factor for CD is determined by HLA-DQ genes. Dysfunction of the innate and adaptive immune systems can conceivably cause impairment of mucosal barrier function and development of localized or systemic inflammatory and autoimmune processes. Exposure to gluten is the main environmental trigger responsible for the signs and symptoms of the disease, but exposure to gluten does not fully explain the manifestation of CD. Thus, both genetic determination and environmental exposure to gluten are necessary for the full manifestation of CD; neither of them is sufficient alone. Epidemiological and clinical data suggest that other environmental factors, including infections, alterations in the intestinal microbiota composition, and early feeding practices, might also play a role in disease development. Thus, this interaction is the condicio sine qua non celiac disease can develop. The breakdown of the interaction among microbiota, innate immunity, and genetic and dietary factors leads to disruption of homeostasis and inflammation; and tissue damage occurs. Focusing attention on this interaction and its breakdown may allow a better understanding of the CD pathogenesis and lead to novel translational avenues for preventing and treating this widespread disease.


Sujet(s)
Maladie coeliaque/immunologie , Maladie coeliaque/microbiologie , Système immunitaire/immunologie , Microbiote/immunologie , Animaux , Maladie coeliaque/génétique , Régime alimentaire/méthodes , Prédisposition génétique à une maladie/génétique , Humains
20.
Euro Surveill ; 17(46)2012 Nov 15.
Article de Anglais | MEDLINE | ID: mdl-23171823

RÉSUMÉ

A national seroprevalence study was performed to determine the prevalence of Haemophilus influenzae type b (Hib) antibodies in England and Wales in 2009, when Hib disease incidence was the lowest ever recorded. A total of 2,693 anonymised residual sera from routine diagnostic testing submitted by participating National Health Service hospital laboratories were tested for Hib anti-polyribosyl-ribitol phosphate (PRP) IgG antibodies using a fluorescent bead assay. Median anti-PRP IgG concentrations were highest in toddlers aged 1­4 years (2.65 µg/ml), followed by children aged 5­9 years (1.95 µg/ml). Antibody concentrations were significantly lower after this age, but were still significantly higher among 10­19 year-olds (0.54 µg/ml) compared with adults aged >20 years (0.16 µg/ ml; p<0.0001). Half of the adults (51%) did not have Hib antibody concentrations ≥0.15 µg/ml, the level considered to confer short-term protection. Thus, the current excellent Hib control appears to be the result of high anti-PRP antibody concentrations in children aged up to 10 years, achieved through the various childhood vaccination campaigns offering booster immunisation. The lack of seroprotection in adults emphasises the importance of maintaining control of the disease and, most probably carriage, in children, therefore raising the question as to whether long-term routine boosting of either pre-school children or adolescents may be required.


Sujet(s)
Anticorps antibactériens/sang , Infections à Haemophilus/épidémiologie , Infections à Haemophilus/immunologie , Vaccins anti-Haemophilus/immunologie , Haemophilus influenzae type B/immunologie , Polyosides bactériens/immunologie , Adolescent , Adulte , Répartition par âge , Facteurs âges , Sujet âgé , Capsules bactériennes/immunologie , Enfant , Enfant d'âge préscolaire , Angleterre/épidémiologie , Femelle , Infections à Haemophilus/prévention et contrôle , Vaccins anti-Haemophilus/administration et posologie , Humains , Immunoglobuline G/sang , Incidence , Nourrisson , Mâle , Adulte d'âge moyen , Polyosides , Études séroépidémiologiques , Sérotypie , Pays de Galles/épidémiologie , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE